Coating Place Strengthens Leadership to Drive Future Growth
Coating Place is embracing an exciting new chapter as it marks its 50th anniversary. This milestone not only highlights the company’s legacy as a frontrunner in Wurster-based fluid bed technology for controlled release and taste masking applications but also sets the stage for future advancements.
Recently, the company announced a significant growth investment designed to fuel its strategic initiatives. This investment comes alongside key leadership appointments aimed at expanding Coating Place's capabilities and enhancing customer service across pharmaceutical and related sectors.
New Appointments Enhance Strategic Direction
Rob Schrepfer now joins Coating Place's Board of Directors. With his current role as President of North American Generics at McKesson, Schrepfer has a wealth of knowledge regarding the markets that Coating Place serves. His strategic insights are expected to play a crucial role in navigating the evolving needs of customers in the industry.
Additionally, Ajay Damani has been appointed as the President of Coating Place, under the guidance of Chief Executive Officer Tim Breunig. Damani's extensive background in the contract development and manufacturing organization (CDMO) sector spans various industries, including pharmaceutical, nutraceutical, and animal health. His commitment to fostering innovative solutions and maintaining strong customer relationships aligns perfectly with the company's objectives.
Commitment to Innovation and Excellence
Coating Place is excited to welcome both Rob Schrepfer and Ajay Damani. Their extensive experience and proven track records are expected to significantly contribute to the company's commitment to innovation and excellence. As Coating Place continues to grow, it aims to enhance its market leadership and expand its capabilities in delivering high-quality services to clients.
With a robust infrastructure exceeding 350,000 square feet across two sites, Coating Place operates under rigorous Good Manufacturing Practice (GMP) quality standards. The company's credibility is reinforced by its registrations with the FDA and Health Canada, as well as DEA licensing. These attributes underscore Coating Place's position as a trusted partner in the development and manufacturing landscape.
Coating Place Overview
As a well-established CDMO, Coating Place specializes in Wurster fluid bed microencapsulation technology, providing advanced solutions tailored to meet diverse industry needs. The organization offers a comprehensive suite of capabilities, including formulation and analytical development, technology transfer, process scale-up, and commercial manufacturing.
The team at Coating Place is dedicated to pushing the boundaries of innovation in the field, consistently responding to the evolving demands of its clientele. This forward-thinking approach ensures that Coating Place remains at the forefront of the industry, well-positioned to adapt and thrive amidst changing market dynamics.
Frequently Asked Questions
What is the significance of the leadership appointments at Coating Place?
The new leadership appointments aim to support Coating Place's strategic growth initiatives and enhance service capabilities in the pharmaceutical industry.
What is Coating Place known for?
Coating Place is recognized for its expertise in Wurster-based fluid bed technology, specializing in controlled release and taste masking applications.
How does the recent investment impact the company?
The growth investment is intended to facilitate strategic initiatives that will expand Coating Place's capabilities and market leadership.
Who are the new leaders joining Coating Place?
Rob Schrepfer has joined the Board of Directors, and Ajay Damani has been appointed as President, both bringing extensive experience in the industry.
What services does Coating Place provide?
Coating Place offers formulation development, analytical development, technology transfer, process scale-up, and commercial manufacturing services across multiple industry segments.
